Maria Sainz

CEO

Hyperfine, Inc. (HYPR)

Board Member

Hyperfine, Inc. (HYPR)

Board Member

Pulse Biosciences, Inc. (PLSE)

Board Member

Orthofix Medical Inc. (OFIX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Pulse Biosciences, Inc. (PLSE)
Board Member

Proxy statement

Current
2025-01-01–present
Orthofix Medical Inc. (OFIX)
Board Member

Proxy statement

Current
2012-01-01–present
Hyperfine, Inc. (HYPR)
CEO

Proxy statement

Current
Hyperfine, Inc. (HYPR)
Board Member

Proxy statement

Current

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Hyperfine, Inc.

HYPR

Current role

CEO, Board Member

16 calls Latest call 2026-08-06

View earnings calls

Orthofix Medical Inc.

OFIX

Current role

Board Member

2012-01-01–present

Pulse Biosciences, Inc.

PLSE

Current role

Board Member

2025-01-01–present

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Hyperfine, Inc. (HYPR)	President and Chief Executive Officer	$582,231	—	—	—	$314,586	—	$896,817
2024	Hyperfine, Inc. (HYPR)	President and Chief Executive Officer	$567,692	—	—	$1,435,000	$266,537	—	$2,269,229
2023	Hyperfine, Inc. (HYPR)	President and Chief Executive Officer	$550,000	—	—	—	$297,000	—	$847,000
2022	Hyperfine, Inc. (HYPR)	President and Chief Executive Officer	$95,192	$125,000	—	$3,077,009	$65,498	$154,550	$3,517,249

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call Hyperfine, Inc. Q2 FY2026 Earnings Call Hyperfine, Inc. (HYPR)
2026-08-06
Earnings call Hyperfine, Inc. Q1 FY2026 Earnings Call Hyperfine, Inc. (HYPR)
2026-05-12
Earnings call Hyperfine, Inc. Q4 FY2025 Earnings Call Hyperfine, Inc. (HYPR)
2026-03-18
Executive change Appointed: Board of Directors Pulse Biosciences, Inc. (PLSE)
2026-01-08
Earnings call Hyperfine, Inc. Q3 FY2025 Earnings Call Hyperfine, Inc. (HYPR)
2025-11-13
Earnings call Hyperfine, Inc. Q2 FY2025 Earnings Call Hyperfine, Inc. (HYPR)
2025-08-13
Earnings call Hyperfine, Inc. Q1 FY2025 Earnings Call Hyperfine, Inc. (HYPR)
2025-05-13
Earnings call Hyperfine, Inc. Q4 FY2024 Earnings Call Hyperfine, Inc. (HYPR)
2025-02-11
Earnings call Hyperfine, Inc. Q3 FY2024 Earnings Call Hyperfine, Inc. (HYPR)
2024-11-12
Earnings call Hyperfine, Inc. Q2 FY2024 Earnings Call Hyperfine, Inc. (HYPR)
2024-08-08
Earnings call Hyperfine, Inc. Q1 FY2024 Earnings Call Hyperfine, Inc. (HYPR)
2024-05-13
Earnings call Hyperfine, Inc. Q4 FY2023 Earnings Call Hyperfine, Inc. (HYPR)
2024-03-21

Show 5 earlier activities

Earnings call Hyperfine, Inc. Q3 FY2023 Earnings Call Hyperfine, Inc. (HYPR)
2023-11-09
Earnings call Hyperfine, Inc. Q2 FY2023 Earnings Call Hyperfine, Inc. (HYPR)
2023-08-14
Earnings call Hyperfine, Inc. Q1 FY2023 Earnings Call Hyperfine, Inc. (HYPR)
2023-05-11
Earnings call Hyperfine, Inc. Q4 FY2022 Earnings Call Hyperfine, Inc. (HYPR)
2023-03-21
Earnings call Hyperfine, Inc. Q3 FY2022 Earnings Call Hyperfine, Inc. (HYPR)
2022-11-10